title: A pilot study of the safety and efficacy of dexamethasone, ifosfamide, methotrexate and gemcitabine chemotherapy for natural killer/T-cell lymphoma.
authors.affiliation: Department of Medical Oncology, Cancer Institute/Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College and Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs , Beijing , China.
authors.forename: Jianliang
authors.initials: J
authors.lastname: Yang
authors.forename: Yuankai
authors.initials: Y
authors.lastname: Shi
authors.forename: Xiaohui
authors.initials: X
authors.lastname: He
authors.forename: Mei
authors.initials: M
authors.lastname: Dong
authors.forename: Changgong
authors.initials: C
authors.lastname: Zhang
authors.forename: Peng
authors.initials: P
authors.lastname: Liu
authors.forename: Shengyu
authors.initials: S
authors.lastname: Zhou
authors.forename: Yan
authors.initials: Y
authors.lastname: Qin
authors.forename: Lin
authors.initials: L
authors.lastname: Gui
authors.forename: Sheng
authors.initials: S
authors.lastname: Yang
authors.forename: Yan
authors.initials: Y
authors.lastname: Sun
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D003907:Dexamethasone / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D054391:Lymphoma, Extranodal NK-T-Cell / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D009367:Neoplasm Staging; D010865:Pilot Projects; D011379:Prognosis; D055815:Young Adult; D000093542:Gemcitabine
chemical_list: D003841:Deoxycytidine; D003907:Dexamethasone; D007069:Ifosfamide; D008727:Methotrexate; D000093542:Gemcitabine